Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

623 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
van der Heijde D, Dijkmans B, Geusens P, Sieper J, DeWoody K, Williamson P, Braun J; Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. van der Heijde D, et al. Among authors: sieper j. Arthritis Rheum. 2005 Feb;52(2):582-91. doi: 10.1002/art.20852. Arthritis Rheum. 2005. PMID: 15692973 Clinical Trial.
No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study.
Sieper J, Fendler C, Laitko S, Sörensen H, Gripenberg-Lerche C, Hiepe F, Alten R, Keitel W, Groh A, Uksila J, Eggens U, Granfors K, Braun J. Sieper J, et al. Arthritis Rheum. 1999 Jul;42(7):1386-96. doi: 10.1002/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E. Arthritis Rheum. 1999. PMID: 10403266 Clinical Trial.
Infliximab treatment of severe ankylosing spondylitis: one-year followup.
Brandt J, Haibel H, Sieper J, Reddig J, Braun J. Brandt J, et al. Among authors: sieper j. Arthritis Rheum. 2001 Dec;44(12):2936-7. doi: 10.1002/1529-0131(200112)44:12<2936::aid-art483>3.0.co;2-m. Arthritis Rheum. 2001. PMID: 11762956 No abstract available.
623 results